Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

Journal of Experimental Medicine

Volumn 188, Issue 12, 1998, Pages 2375-2380

  Zamai, Loris ^a,b   Ahmad, Manzoor ^a   Bennett, Ian M ^a   Azzoni, Livio ^a   Alnemri, Emad S ^a   Perussia, Bice ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF URBINO   (Italy)

Author keywords

Cytotoxicity; Differentiation; Fas ligand; Natural killer cells; TRAIL

Indexed keywords

CD1 ANTIGEN; CD56 ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL MATURATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; NATURAL KILLER CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM; CELL DEGRANULATION; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; HUMANS; INTERLEUKINS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032447111     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.12.2375     Document Type: Article

References (13)

1. Montel, A.H., M.R. Bochan, W.S. Goebel, and Z. Bramhi. 1995. Fas-mediated cytotoxicity remains intact in perform and granzyme B antisense transfectants of a human NK-like cell line. Cell. Immunol. 165:312-317.
2. Lee, P.K., J. Spielman, D.Y. Zhao, K.J. Olsen, and E.R. Podack. 1996. Perform, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells J. Immunol 157:1919-1925.
3. Perez, C., I. Albert, K. DeFay, N. Zacharides, L. Gooding, and M. Kriegler. 1990. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell. 63:251-258.
4. Oshimi, Y., S. Oda, Y. Honda, S. Nagata, and S. Miyazaki. 1996. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157:2909-2915.
5. Lowin, B., M.C. Peitsch, and J. Tschopp. 1995. Perform and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol. 198:1-24.
6. Berke, G. 1994. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12:735-773.
7. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science. 267:1449-1456.
8. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932-10937.
9. Cohen, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1-16.
10. MacFarlane, M., A. Manzoor, S.M. Srinivasula, T. Fernandes-Alnemri, G.M. Cohen, and E.S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 41:25417-25420.
11. Chaudhary, P.M., M. Eby, A. Jasmin, A. Bookwalter, J. Murray, and L. Hood. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate NF-κB. Immunity. 7:821-830.
12. Walczak, H., M.A. Degli-Esposti, R.S. Johnson, P.J. Smolak, J.Y. Waugh, N. Boiani, M.S. Timour, M.J. Gerhart, K.A. Schooley, C.A. Smith, et al. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO (Eur. Mol. Biol. Organ.) J. 16:5386-5397.
13. Wiley, S.R., K. Schooley, P.J. Smolak, W.S. Din, C.P. Huang, J.K. Nicholl, G.R. Sutherland, T.D. Smith, C. Rauch, and C.A. Smith. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:673-682.